PLMR reports Q2 2026 results today having slipped 5% on the week to $136.11, underperforming most of its insurance peers, which fell 1–4% over the same stretch — while ACIC and ORI actually gained ground.
The most telling signal heading into the print is how uniformly analysts have re-rated higher in recent weeks. JP Morgan lifted its target from $150 to $167 on July 20, keeping an Overweight rating. Piper Sandler moved from $132 to $165 in mid-July, and Keefe, Bruyette & Woods nudged from $162 to $166 in early July. All three had cut targets in May following Q2 2025's elevated loss ratios — the reversal is sharp, and the mean target of $164 now implies roughly 20% upside from the current price. The message from the Street is consistent: near-term execution stumbles were treated as transitory, and the pricing-cycle tailwind has been re-embraced.
The bull case rests on whether that re-rating is deserved. Analysts are modelling improving core loss ratios as insurance pricing peaks convert to earned premium, alongside a higher net-to-gross ratio and rising EPS estimates across 2025–2027. Bears point to the same Q2 2025 print that already rattled the stock: earthquake gross written premiums slowed, loss ratios ran hot, and the crop segment's heavy ceding structure drags on net profitability. Neither side has moved PLMR's EPS-surprise factor score into genuinely impressive territory — it ranks in the 33rd percentile — so consistent beats are not yet a structural part of this story.
Positioning is notably calm for an earnings day. Short interest is a relatively modest 4.3% of free float, and has edged only marginally higher on the month — not the aggressive accumulation pattern that would signal a crowded short. Borrow availability is extremely loose at roughly 2,500% of short interest, meaning shares to borrow are abundant and borrowing costs remain negligible at under 0.5%. Options positioning has ticked slightly more defensive into today — the put/call ratio at 0.20 is running about 1.8 standard deviations above its 20-day average — but the absolute level is still extremely low by any historical measure, with the 52-week high sitting at 0.61. The setup reads as mild caution, not fear.
The print is therefore less a test of whether Palomar's model works and more a test of whether the structural improvement that analysts re-priced in July actually shows up in the Q2 numbers — particularly in loss ratios and earthquake premium growth, where the last disappointment originated.
See the live data behind this article on ORTEX.
Open PLMR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
